Literature DB >> 23637481

Characterization and expression of e2 glycoprotein of classical Swine Fever virus in a eukaryotic expression system.

Barkha Ratta1, Binita Nautiyal, P V Ravindra, Uttara Chaturvedi, Sudesh Kumar, P K Subudhi, Kantaraja Chindera, Sangeeta Tiwari, N N Barman, Ashok K Tiwari.   

Abstract

Classical swine fever (CSF) is an economically important Office International des Epizooties (OIE) list A disease of swine characterized by high fever and multiple haemmorhages. The E2 glycoprotein of CSFV is immunogenic and induces neutralizing antibodies against CSFV. In the present study, complete coding region of the E2 gene from Indian virulent field isolate (Mathura) was amplified by reverse transcription-polymerase chain reaction (RT-PCR) and subsequently cloned into a mammalian expression vector; pcDNA3.1(+) at BamHI and XbaI site. The recombinant plasmid; pcDNA.E2.CSFV. was confirmed by restriction enzyme digestion. The pcDNA.E2.CSFV. transfected Vero cell expressed E2 protein which was confirmed by western blotting, immunoperoxidase and indirect immunofluorescent tests. Additionally, flow cytometry analysis also confirmed that 15% of transfected Vero cells expressed the E2 glycoprotein compared to mock or vector alone transfected cells. Further study is under way to evaluate recombinant pcDNA.E2.CSFV. Mathura clone as DNA vaccine against CSFV.

Entities:  

Keywords:  Classical swine fever (CSF); Classical swine fever virus (CSFV); Reverse transcription-polymerase chain reaction (RT-PCR)

Year:  2010        PMID: 23637481      PMCID: PMC3550772          DOI: 10.1007/s13337-010-0009-9

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  21 in total

1.  Detection and characterisation of bluetongue virus using the polymerase chain reaction.

Authors:  K A McColl; A R Gould
Journal:  Virus Res       Date:  1991-09       Impact factor: 3.303

2.  Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de-novo protein synthesis and caspase activation.

Authors:  P V Ravindra; Ashok K Tiwari; Barkha Ratta; Uttara Chaturvedi; Sudesh Kumar Palia; Prasant Kumar Subudhi; Rajiv Kumar; Bhaskar Sharma; Anant Rai; R S Chauhan
Journal:  Virus Res       Date:  2008-03-10       Impact factor: 3.303

3.  An improved ELISA for the detection of serum antibodies directed against classical swine fever virus.

Authors:  E O Colijn; M Bloemraad; G Wensvoort
Journal:  Vet Microbiol       Date:  1997-12       Impact factor: 3.293

4.  Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge.

Authors:  P A van Rijn; A Bossers; G Wensvoort; R J Moormann
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

5.  DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection.

Authors:  M Yokoyama; J Zhang; J L Whitton
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model.

Authors:  D L Suarez; S Schultz-Cherry
Journal:  Avian Dis       Date:  2000 Oct-Dec       Impact factor: 1.577

Review 7.  Introduction to classical swine fever: virus, disease and control policy.

Authors:  V Moennig
Journal:  Vet Microbiol       Date:  2000-04-13       Impact factor: 3.293

8.  N-linked glycosylation status of classical swine fever virus strain Brescia E2 glycoprotein influences virulence in swine.

Authors:  G R Risatti; L G Holinka; I Fernandez Sainz; C Carrillo; Z Lu; M V Borca
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

Review 9.  Novel marker vaccines against classical swine fever.

Authors:  Martin Beer; Ilona Reimann; Bernd Hoffmann; Klaus Depner
Journal:  Vaccine       Date:  2007-01-04       Impact factor: 3.641

10.  High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus.

Authors:  K S Lundberg; D D Shoemaker; M W Adams; J M Short; J A Sorge; E J Mathur
Journal:  Gene       Date:  1991-12-01       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.